Literature DB >> 18331287

Head and neck squamous cell carcinoma in non-smoking and non-drinking patients with multiple tumors: etiologic significance of p53 and Ki-67 in non-tumorous epithelium.

F Farshadpour1, G J Hordijk, R Koole, P J Slootweg.   

Abstract

BACKGROUND: Non-smoking and non-drinking patients with head and neck squamous cell carcinoma have different clinical characteristics than their smoking and drinking counterparts. They are predominantly older female patients with oral cavity tumors, however, both groups show the same percentage of second primary tumors. Expression of tumor suppressor gene p53 and proliferation marker Ki-67 in mucosal epithelial cells was analyzed to study whether biomarker expression is associated with a history of smoking and drinking and with single and multiple tumors.
METHODS: Non-smoking and non-drinking patients with multiple (n = 18) and single tumors (n = 15), smoking and drinking patients with multiple (n = 15) and single tumors (n = 14) were selected. For all groups, p53 and Ki-67 expression patterns in non-tumorous (tumor-adjacent) mucosa including positivity of dispersed single cells and clusters for p53 and for suprabasal expression of Ki-67 were immunohistochemically analyzed and compared.
RESULTS: p53 expression was significantly higher in users of tobacco and alcohol than in non-users. Ki-67 expression was not affected by tobacco and alcohol usage. Both Ki-67 and p53 were similarly expressed in the groups with single and multiple tumors and hence not significantly related to the number of tumors.
CONCLUSIONS: Non-smoking and non-drinking patients with squamous cell carcinoma have the same risk for developing multiple tumors as their smoking and drinking counterparts. As this occurs without an increased expression of p53 or Ki-67, the significance of these proteins as biomarkers indicating pre-malignant mucosal alterations is doubtful. Further research is needed to clarify this predisposition for developing multiple head and neck cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18331287     DOI: 10.1111/j.1600-0714.2008.00657.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  6 in total

1.  A80G polymorphism of reduced folate carrier 1 (RFC1) gene and head and neck squamous cell carcinoma etiology in Brazilian population.

Authors:  Ana Lívia Silva Galbiatti; Mariangela Torreglosa Ruiz; Daniela Rezende Pinto; Luiz Sérgio Raposo; José Victor Maníglia; Erika Cristina Pavarino-Bertelli; Eny Maria Goloni-Bertollo
Journal:  Mol Biol Rep       Date:  2010-07-27       Impact factor: 2.316

2.  The association between CBS 844ins68 polymorphism and head and neck squamous cell carcinoma risk - a case-control analysis.

Authors:  Ana L S Galbiatti; Mariangela T Ruiz; Luis S Raposo; José V Maniglia; Erika C Pavarino-Bertelli; Eny M Goloni-Bertollo
Journal:  Arch Med Sci       Date:  2010-10-26       Impact factor: 3.318

3.  Presence of Human Papillomavirus and Epstein-Barr Virus, but Absence of Merkel Cell Polyomavirus, in Head and Neck Cancer of Non-Smokers and Non-Drinkers.

Authors:  Frans J Mulder; Faisal Klufah; Famke M E Janssen; Farzaneh Farshadpour; Stefan M Willems; Remco de Bree; Axel Zur Hausen; Mari F C M van den Hout; Bernd Kremer; Ernst-Jan M Speel
Journal:  Front Oncol       Date:  2021-01-20       Impact factor: 6.244

4.  Molecular drivers of oral cavity squamous cell carcinoma in non-smoking and non-drinking patients: what do we know so far?

Authors:  Sophia Uddin; Alka Singh; Vasudha Mishra; Nishant Agrawal; Zhen Gooi; Evgeny Izumchenko
Journal:  Oncol Rev       Date:  2022-02-22

5.  Polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene and risk of head and neck squamous cell carcinoma.

Authors:  Juliana Olsen Rodrigues; Ana Lívia Silva Galbiatti; Mariangela Torreglosa Ruiz; Luiz Sergio Raposo; José Victor Maniglia; Erika Cristina Pavarino-Bertelli; Eny Maria Goloni-Bertollo
Journal:  Braz J Otorhinolaryngol       Date:  2010 Nov-Dec

6.  An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma.

Authors:  Dayang Chen; Mengmeng Wang; Ying Guo; Wei Wu; Xiang Ji; Xiaowen Dou; Huamei Tang; Zengyan Zong; Xiuming Zhang; Dan Xiong
Journal:  Cancer Med       Date:  2021-07-27       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.